Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Status: Publicly traded
Direct answer
Suzhou Zelgen Biopharmaceuticals Co., Ltd. is publicly traded on SHH under the ticker 688266.SS.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. is a Chinese company engaged in the entire lifecycle of pharmaceutical products, from research and development to manufacturing and sales, within the People's Republic of China. Their product portfolio encompasses both small molecule and recombinant protein-based drugs, which are developed to treat a variety of serious health conditions. These include several types of...
Can you invest in Suzhou Zelgen Biopharmaceuticals Co., Ltd.?
Yes. Suzhou Zelgen Biopharmaceuticals Co., Ltd. is publicly traded on SHH under the ticker 688266.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Detailed equity research is provided by MarketSnap.